TWO · 6549.TWO
TaiwanJ Pharmaceuticals Co., Ltd.
NT$6.79-NT$0.04 (-0.59%)
TaiwanJ Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.71% below the high.
Loading market information…
TWO · 4115.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Sunder Biomedical Tech. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sunder Biomedical Tech. Co., Ltd.’s forward annual dividend is NT$0.30 per share, paid annual. The forward yield is 4.3% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
Sunder Biomedical Tech. Co., Ltd. is engaged in the manufacturing and distribution of a diverse range of medical devices. Their extensive product portfolio features essential items such as personal protective equipment, including safety goggles and masks crafted from melt-blown nonwoven fabric. The company further provides specialized medical and surgical consumables like suction-irrigation systems, smoke filters, endo bags, and critical supplies for hemodialysis, including blood line sets and A.V. fistula needle sets. Additionally, they offer various intravenous (I.V.) administration apparatus, extension tubes, volume-controlled I.V. sets, surgical tubing kits, standalone components, and transducer protectors. Medical-grade PVC compounds are also among their offerings. Established in 1998, Sunder Biomedical maintains its operational base in Taichung, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:49 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$6.79-NT$0.04 (-0.59%)
TaiwanJ Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.71% below the high.
NT$12.00NT$0.00 (0.0%)
Vectorite Biomedical Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.88% below the high.
NT$9.72+NT$0.15 (+1.57%)
Health & Life Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.97% below the high.
NT$12.60+NT$0.15 (+1.2%)
UniPharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.25% below the high.
NT$11.70+NT$2.40 (+25.81%)
DuoGenic StemCells corporation’s quoted price sits in the lower half of its reported 52-week range, 45.58% below the high.
NT$29.90-NT$0.60 (-1.97%)
A-SPINE Asia Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.17% below the high.
NT$7.78+NT$0.33 (+4.43%)
Pharmigene, Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.35% below the high.
NT$16.60-NT$0.60 (-3.49%)
Welgene Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.43% below the high.
